Canada authorises compulsory licences for COVID-19 shortfalls

Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Nova seeks to cut Dow’s $517m award in Canada

21 April 2022 Nova Chemicals has asked Canada’s top court to revisit a historic patent damages award of CAD$645 million won by Dow Chemical at the country’s federal court of appeal.

Americas

Canada's drug pricing plan prompts backlash

26 October 2020 The final version of guidelines issued by Canada’s federal drug price regulator last week has caused uproar among the pharma industry.

Americas

Why things could get ugly over COVID-19 patents

30 April 2020 Foreign patents protecting COVID-19 treatments may stall efforts to protect citizens, says Mark Engelman of Hardwicke chambers.

More on this story

Big Pharma

Nova seeks to cut Dow’s $517m award in Canada

21 April 2022 Nova Chemicals has asked Canada’s top court to revisit a historic patent damages award of CAD$645 million won by Dow Chemical at the country’s federal court of appeal.

Americas

Canada's drug pricing plan prompts backlash

26 October 2020 The final version of guidelines issued by Canada’s federal drug price regulator last week has caused uproar among the pharma industry.

Americas

Why things could get ugly over COVID-19 patents

30 April 2020 Foreign patents protecting COVID-19 treatments may stall efforts to protect citizens, says Mark Engelman of Hardwicke chambers.

More on this story

Big Pharma

Nova seeks to cut Dow’s $517m award in Canada

21 April 2022 Nova Chemicals has asked Canada’s top court to revisit a historic patent damages award of CAD$645 million won by Dow Chemical at the country’s federal court of appeal.

Americas

Canada's drug pricing plan prompts backlash

26 October 2020 The final version of guidelines issued by Canada’s federal drug price regulator last week has caused uproar among the pharma industry.

Americas

Why things could get ugly over COVID-19 patents

30 April 2020 Foreign patents protecting COVID-19 treatments may stall efforts to protect citizens, says Mark Engelman of Hardwicke chambers.